We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Huntleigh Diagnostics

Featured Products: More products

Download Mobile App





Huntleigh Presents Innovative Solutions in Vascular Care, Fetal and Patient Monitoring at MEDICA 2021

By HospiMedica International staff writers
Posted on 18 Nov 2021

Huntleigh Healthcare Ltd. More...

(Wales, UK), a member of the Arjo family, presented its innovative solutions in vascular care, fetal and patient monitoring at MEDICA 2021.

MEDICA, the world's largest annual medical technology trade fair, took place from 15-18 November in Düsseldorf, Germany. At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries. At MEDICA 2021, Huntleigh presented its Sonicaid Fetal Doppler product portfolio, which encompasses Sonicaid Digital SR2/SR3 2&3 MHz Waterproof Rate Display Dopplers, Sonicaid SRX Digital Doppler, Sonicaid D920/D930 Waterproof Audio Dopplers, and the Sonicaid FD1/FD3 2&3MHz Waterproof Dopplers.

These high sensitivity handheld Digital Dopplers are intended for general purpose screening of the fetal heart at all stages of pregnancy from as early as 8-10 weeks, right through to labor. The attached probes are waterproof (IPX7) for high sensitivity FHR detection in both normal use and in waterbirth monitoring. The high performance transducer enables reliable detection from early gestation right through to delivery, even on obese patients. In addition, Huntleigh displayed its new range of high sensitivity XS probes that have been designed, calibrated and fine-tuned to provide excellent performance over the widest gestational age and BMI range in all clinical settings.

Huntleigh also showcased its Smartsigns patient monitoring range which is capable of delivering a wide range of monitoring options, ranging from hand held or portable devices. Smartsigns patient monitors can be used to monitor the patient’s basic vital signs, through to advanced modular systems used in many low, medium & high acuity settings throughout all areas of healthcare. Huntleigh particularly highlighted its new SC500 Series vital signs monitor which comes with an integrated Early Warning scoring tool (MEWS & NEWS2), and three level alarms, making it ideal for long COVID measurements and observations.

Huntleigh’s extensive experience in vascular assessment was evident at MEDICA 2021, as the company showcased its technologically advanced range of products to improve the efficiency and effectiveness in vascular diagnosis. Huntleigh displayed its Dopplex Ability Automatic Automatic Ankle Brachial Index (ABI) System which has revolutionized the ABI process and provides automatic, easy, fast and accurate measurements with an immediate printout of results from the integral printer or optional DR4 software package. Also on display was the company’s entire vascular assessment Dopplers & kits product portfolio, including Dopplex D900, Dopplex SD2, Dopplex ABI Kit and Dopplex ATP Kit. Huntleigh also displayed its LymphAssist Professional 12 Chamber Intermittent Pneumatic Compression (IPC) System which has been designed to offer clinicians a multi modal treatment option to manage Lymphoedema and associated conditions.

Related Links:
Huntleigh Healthcare Ltd. 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Short Phlebotomy Cart
MSWA-3469-WHT
New
High-Precision QA Tool
DEXA Phantom
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.